Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-Dose IMRT vs IMRT + ADT in Prostate Cancer
NCT00067015Phase 3Completed
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Start
- May 2003
- Primary completion
- Oct 2004
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of bicalutamide, goserelin in prostate cancer (PCa), sponsored by Memorial Sloan Kettering Cancer Center. Started May 2003; status: completed.
02
Drugs
bicalutamidegoserelin
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00067015.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00067015.